Fig. 4.
Relative expression of βIT mRNA as detected by RNAse protection assays (•) or semiquantitative RT-PCR (○) on total RNA from hematopoietic cell lines, primary myeloid cells, and leukemic blasts of patients with ALL or AML of varying FAB types (M0 to M6).